Sort by
Refine Your Search
-
interactions. The DYNABIO PhD Program The DYNABio doctoral programme offers fully funded 3-year PhD fellowships across a wide range of cellular and molecular biology topics, within an internationally visible and
-
The Center for Interdisciplinary Cardiovascular Sciences (CICS), directed by Masanori Aikawa, MD, PhD, at Brigham and Women’s Hospital and Harvard Medical School is seeking a postdoctoral research
-
should have a PhD in a relevant subject. This is a training position to provide a pathway back to science for those who have, for whatever reason, stepped away from science, perhaps due to caring
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
About us The UCL Laboratory for Molecular Cell Biology (LMCB, http:/www.ucl.ac.uk/lmcb) is an internationally renowned, multidisciplinary, molecular and cell biology department, located in the heart
-
We are seeking a highly motivated and skilled Postdoctoral Fellow to lead this innovative research program at the interface of proteostasis and transplantation biology. The successful candidate will
-
with therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD, at the University of Texas MD Anderson Cancer Center
-
academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular Networks, and
-
benefit from participation in the UT Southwestern Postdoctoral Training Program. Information on our postdoctoral training program, benefits and a virtual tour can be found at http://www.utsouthwestern.edu
-
applicants to join us and experience what it means to be part of Mass General Brigham. The DeKosky Laboratory for Immune Engineering and Drug Discovery is hiring a researcher to advance computational drug